Bone and joint disorder after Bedinvetmab (Librela) in dogs
379 reports to the FDA describe bone and joint disorder in dogs given Bedinvetmab. That is 1.9% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.
379Reports
67%Marked serious
1.8%Recovered
14%Died or euthanised
34 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Bedinvetmab reduces osteoarthritis pain in dogs (monthly injection).
Products with this ingredient include Librela. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Bedinvetmab cause bone and joint disorder in dogs?
- 379 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 34 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Bone and joint disorder with similar medicines
- Bone and joint disorder after Lokivetmab (Cytopoint) 25 reports · 0.4% of its reports
All reported side effects of Bedinvetmab in dogs · Medicines most reported with bone and joint disorder